STAT+: Pharmalittle: Justice Department probes Bausch over marketing; Pfizer to seek Covid booster for healthy 5- to 11-year-olds
Rise and shine, everyone, another busy day is on the way. We can tell because we have already made the rounds at the local airport, where we scooped up one of the short people and are now busy arranging our calendar for the next few hours. No doubt, you can relate. So time to fire up the coffee kettle, yes? Our choice today is gingerbread spice. As always, you are welcome to join us. We enjoy the company. Now, though, it is time to get cracking. So here is the latest laundry list of interesting items for you to peruse. We hope you have a meaningful and productive day. And of course, do keep in touch. As the first item indicates, we accept secret dossiers. …
Bausch Health is being investigated by U.S. authorities in connection with marketing of four medicines used to treat different skin conditions, STAT reports. The U.S. Department of Justice sent a civil investigative demand last year to the company seeking information about various activities in which the medicines may have been promoted for uses not approved by regulators. The inquiry is focused on three drugs used to treat plaque psoriasis — Bryhali, Siliq, and Duobrii – and a fungal treatment called Jublia. The Justice Department is also interested in any financial assistance that may have been provided to Medicare patients who were prescribed Siliq.
Continue to STAT+ to read the full story…
